Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 3586 AL 3600

The Microbiome as a Modifier of Neurodegenerative Disease Risk

Fang P, Kazmi SA, Jameson KG, Hsiao EY.

Cell Host Microbe. 2020 Aug 12;28(2):201-222. doi: 10.1016/j.chom.2020.06.008.

Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities

Tabrizi SJ, Flower MD, Ross CA, Wild EJ.

Nat Rev Neurol. 2020 Oct;16(10):529-546. doi: 10.1038/s41582-020-0389-4. Epub 2020 Aug 14.

Manganese-induced neurodegenerative diseases and possible therapeutic approaches

Martins AC Jr, Gubert P, Villas Boas GR, Meirelles Paes M, Santamaría A, Lee E, Tinkov AA, Bowman AB, Aschner M.

Expert Rev Neurother. 2020 Nov;20(11):1109-1121. doi: 10.1080/14737175.2020.1807330. Epub 2020 Sep 2.

Mesenchymal stromal cells (MSCs) for neurodegenerative disease: A promising frontier

Shariati A, Nemati R, Sadeghipour Y, Yaghoubi Y, Baghbani R, Javidi K, Zamani M, Hassanzadeh A.

Eur J Cell Biol. 2020 Aug;99(6):151097. doi: 10.1016/j.ejcb.2020.151097. Epub 2020 Jun 26.

Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome

Sciascia S, Radin M, Ramirez C, Seaman A, Bentow C, Casas S, Cecchi I, Rubini E, Foddai SG, Baldovino S, Fenoglio R, Menegatti E, Roccatello D, Mahler M.

Autoimmun Rev. 2020 Oct;19(10):102641. doi: 10.1016/j.autrev.2020.102641. Epub 2020 Aug 13.

MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases

Catanesi M, d'Angelo M, Tupone MG, Benedetti E, Giordano A, Castelli V, Cimini A.

Int J Mol Sci. 2020 Aug 20;21(17):5986. doi: 10.3390/ijms21175986.

Transient knots in intrinsically disordered proteins and neurodegeneration

Cieplak M, Chwastyk M, Mioduszewski Ł, de Aquino BRH.

Prog Mol Biol Transl Sci. 2020;174:79-103. doi: 10.1016/bs.pmbts.2020.03.003. Epub 2020 Apr 9.

Mitochondrial abnormalities in neurodegenerative models and possible interventions: Focus on Alzheimer's disease, Parkinson's disease, Huntington's disease

Pantiya P, Thonusin C, Chattipakorn N, Chattipakorn SC.

Mitochondrion. 2020 Nov;55:14-47. doi: 10.1016/j.mito.2020.08.003. Epub 2020 Aug 20.

Review of Hereditary and Acquired Rare Choreas

Martinez-Ramirez D, Walker RH, Rodríguez-Violante M, Gatto EM; Rare Movement Disorders Study Group of International Parkinson’s Disease.

Tremor Other Hyperkinet Mov (N Y). 2020 Aug 6;10:24. doi: 10.5334/tohm.548.

Shared perturbations in the metallome and metabolome of Alzheimer's, Parkinson's, Huntington's, and dementia with Lewy bodies: A systematic review

Scholefield M, Unwin RD, Cooper GJS.

Ageing Res Rev. 2020 Nov;63:101152. doi: 10.1016/j.arr.2020.101152. Epub 2020 Aug 23.

Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases?

Salado-Manzano C, Perpiña U, Straccia M, Molina-Ruiz FJ, Cozzi E, Rosser AE, Canals JM.

Front Cell Neurosci. 2020 Aug 11;14:250. doi: 10.3389/fncel.2020.00250. eCollection 2020.

Phase Transition of Huntingtin: Factors and Pathological Relevance

Yang J, Yang X.

Front Genet. 2020 Jul 23;11:754. doi: 10.3389/fgene.2020.00754. eCollection 2020.

LncRNA Xist, X-chromosome Instability and Alzheimer's Disease

Chanda K, Mukhopadhyay D.

Curr Alzheimer Res. 2020;17(6):499-507. doi: 10.2174/1567205017666200807185624.

Enhancing mitophagy as a therapeutic approach for neurodegenerative diseases

Aman Y, Ryan B, Torsetnes SB, Knapskog AB, Watne LO, McEwan WA, Fang EF.

Int Rev Neurobiol. 2020;155:169-202. doi: 10.1016/bs.irn.2020.02.008. Epub 2020 Aug 11.

Antioxidant Modulation of mTOR and Sirtuin Pathways in Age-Related Neurodegenerative Diseases

Abdullah A, Mohd Murshid N, Makpol S.

Mol Neurobiol. 2020 Dec;57(12):5193-5207. doi: 10.1007/s12035-020-02083-1. Epub 2020 Aug 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias